Cutaneous pseudolymphoma successfully treated with dupilumab
Eur J Dermatol
.
2023 Jun 1;33(3):307-309.
doi: 10.1684/ejd.2023.4482.
Authors
Shuji Sugiura
,
Takeshi Nakanishi
,
Noriki Fujimoto
PMID:
37594345
DOI:
10.1684/ejd.2023.4482
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Pseudolymphoma* / drug therapy
Substances
dupilumab
Antibodies, Monoclonal, Humanized